Name:
MMB-CHMICA, AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1 H-indole-3-carboxamido)-3-methylbutanoate)
Type:
Synthetic cannabinoid
AKA:
N/A
MMB-CHMICA, AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1 H-indole-3-carboxamido)-3-methylbutanoate) image
Synthetic substance, no natural derivative
IUPAC Logo
MMB-CHMICA, AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1 H-indole-3-carboxamido)-3-methylbutanoate) image
MMB-CHMINACA and AMB-CHMINACA are synthetic cannabinoids developed in the 2010s. They are part of research into synthetic cannabinoids, designed to mimic THC's effects. Their recreational use has raised concerns, leading to their regulation due to safety and abuse potential.
Synthetic Substances Image
MMB-CHMICA and AMB-CHMICA are synthetic cannabinoids with potent psychoactive effects. They increase heart rate and blood pressure, acting as uppers. Short-term use may lead to intense psychoactive effects, while long-term use poses risks of cardiovascular issues and psychological problems. Overdose risks include severe agitation, hallucinations, and cardiovascular effects. Safe use involves cautious dosing and monitoring. Recent research focuses on their psychoactive effects and associated health risks.
N/A
MMB-CHMINACA and AMB-CHMINACA, synthetic cannabinoids, affect cannabinoid receptors, leading to altered mood and perception. Immediate effects include euphoria and relaxation, while long-term use may cause cognitive impairments and psychological issues. Research examines their potency and psychological impact.
N/A
MMB-CHMINACA and AMB-CHMINACA are synthetic cannabinoids with no historical lore, emerging in the 21st century. Their cultural impact is related to their use as legal highs and associated health risks. Proponents highlight their effects, while opponents caution about health dangers and regulatory challenges. Their use is primarily recreational, reflecting broader issues in synthetic drug use and regulation.
N/A